SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-020163
Filing Date
2023-07-18
Accepted
2023-07-18 16:27:35
Documents
18
Period of Report
2023-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20230718_8k.htm   iXBRL 8-K 37671
2 EXHIBIT 5.1 ex_545119.htm EX-5.1 15191
3 EXHIBIT 10.1 ex_545120.htm EX-10.1 213643
8 a1.jpg GRAPHIC 2866
9 a2.jpg GRAPHIC 11455
10 a3.jpg GRAPHIC 11194
  Complete submission text file 0001437749-23-020163.txt   504143

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20230718.xsd EX-101.SCH 3891
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20230718_def.xml EX-101.DEF 13443
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20230718_lab.xml EX-101.LAB 17670
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20230718_pre.xml EX-101.PRE 13420
12 EXTRACTED XBRL INSTANCE DOCUMENT govx20230718_8k_htm.xml XML 4397
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 231094534
SIC: 2834 Pharmaceutical Preparations